Procurement of Elosulfatase alfa (Vimizim)
Seeking Elosulfatase alfa (Vimizim), a recombinant enzyme for treating Morquio A syndrome. The estimated cost is approximately 3 million Euros.
CONTRACTING AUTHORITY
Name
HUS Group, the joint authority for Helsinki and Uusimaa — HUS Apteekki
Country
FI
CLASSIFICATION
Procedure Type
neg-wo-call
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
182 days remaining(LOT-0000)
Published